RX&D Code of Marketing Practices
MISSION STATEMENT
Download a Rx&D Code of Conduct PDF
Members of Rx&D share the mission to improve the health of Canadians through the discovery, development, manufacture, and distribution of innovative prescription medicines. Implicit in this mission are commitments to undertake and promote research, to product stewardship, to ensure that healthcare providers and patients receive the education and information to use Rx&D members’ products and services appropriately, and for members to observe their social responsibilities and role to improve the health and social environments that Canadians enjoy.
Canada’s Research-Based Pharmaceutical Companies (Rx&D) are aware of and adhere to the ideals of a free and fair society. These ideals include individual freedom, respect for the views of others, the freedom to trade and carry on commerce and the freedom that allows science and medicine to advance their knowledge bases.
In recognition of its role in the international pharmaceutical community, Rx&D is a member of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). The IFPMA is a non-governmental organization representing pharmaceutical associations in 51 countries around the world. Part of its mission is:
“To promote and support continuous development, throughout the pharmaceutical industry, of ethical principles and practices voluntarily agreed on…”
As a member of the IFPMA, Rx&D strongly supports IFPMA’s mission and the principles of its Code of Pharmaceutical Marketing Practices. Rx&D urges its member companies to publicly affirm their corporate commitment to honour the principles and ideals that IFPMA has set for pharmaceutical industry.